ROBUST MIXED EFFECTS MODEL FOR CLUSTERED FAILURE TIME DATA: APPLICATION TO HUNTINGTON'S DISEASE EVENT MEASURES.

about

ROBUST MIXED EFFECTS MODEL FOR CLUSTERED FAILURE TIME DATA: APPLICATION TO HUNTINGTON'S DISEASE EVENT MEASURES.

Item

http://www.wikidata.org/entity/Q49334635

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

ROBUST MIXED EFFECTS MODEL FOR ...... GTON'S DISEASE EVENT MEASURES.

@en

ROBUST MIXED EFFECTS MODEL FOR ...... GTON'S DISEASE EVENT MEASURES.

@nl

type

Item

label

ROBUST MIXED EFFECTS MODEL FOR ...... GTON'S DISEASE EVENT MEASURES.

@en

ROBUST MIXED EFFECTS MODEL FOR ...... GTON'S DISEASE EVENT MEASURES.

@nl

prefLabel

ROBUST MIXED EFFECTS MODEL FOR ...... GTON'S DISEASE EVENT MEASURES.

@en

ROBUST MIXED EFFECTS MODEL FOR ...... GTON'S DISEASE EVENT MEASURES.

@nl

P1476

ROBUST MIXED EFFECTS MODEL FOR ...... GTON'S DISEASE EVENT MEASURES.

@en

P2093

Karen Marder

http://www.w3.org/2001/XMLSchema#string

Tanya P Garcia

http://www.w3.org/2001/XMLSchema#string

Yanyuan Ma

http://www.w3.org/2001/XMLSchema#string

Yuanjia Wang

http://www.w3.org/2001/XMLSchema#string

P2860

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Conditional and Marginal Estimates in Case-Control Family Data - Extensions and Sensitivity Analyses.

ANALYSIS OF MULTIVARIATE FAILURE TIME DATA USING MARGINAL PROPORTIONAL HAZARDS MODEL.

Accuracy of family history data on Parkinson's disease.

Modelling clustered survival data from multicentre clinical trials.

On robustness of marginal regression coefficient estimates and hazard functions in multivariate survival analysis of family data when the frailty distribution is mis-specified.

Automated detection of infectious disease outbreaks in hospitals: a retrospective cohort study.

Marginal models for clustered time-to-event data with competing risks using pseudovalues

Huntington's disease: from molecular pathogenesis to clinical treatment.

Mild cognitive impairment in prediagnosed Huntington disease.

P304

1085-1116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1214/17-AOAS1038

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29399240

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5793916

http://www.w3.org/2001/XMLSchema#string